Lantheus Holdings, Inc. (LNTH)
NASDAQ: LNTH · Real-Time Price · USD
101.77
-1.87 (-1.80%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Lantheus Holdings Revenue
In the year 2024, Lantheus Holdings had annual revenue of $1.53B with 18.32% growth. Lantheus Holdings had revenue of $391.11M in the quarter ending December 31, 2024, with 10.48% growth.
Revenue (ttm)
$1.53B
Revenue Growth
+18.32%
P/S Ratio
4.59
Revenue / Employee
$1,898,403
Employees
808
Market Cap
6.98B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.53B | 237.48M | 18.32% |
Dec 31, 2023 | 1.30B | 361.37M | 38.65% |
Dec 31, 2022 | 935.06M | 509.85M | 119.91% |
Dec 31, 2021 | 425.21M | 85.80M | 25.28% |
Dec 31, 2020 | 339.41M | -7.93M | -2.28% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.90B |
LNTH News
- 2 days ago - Lantheus to Host First Quarter 2025 Earnings Conference Call and Webcast on May 7, 2025, at 8:00 a.m. Eastern Time - GlobeNewsWire
- 24 days ago - Lantheus Completes Acquisition of Evergreen Theragnostics - GlobeNewsWire
- 7 weeks ago - Lantheus Holdings: Pylarify Makes Bull Case Despite Looming Patent Expiry - Seeking Alpha
- 2 months ago - Lantheus Holdings, Inc. (LNTH) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Lantheus Appoints Phuong Khanh (P.K.) Morrow, M.D. - GlobeNewsWire
- 3 months ago - Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive Strategic Evolution into Fully Integrated Radiopharmaceutical Leader - PRNewsWire
- 3 months ago - Lantheus to Acquire Life Molecular Imaging for an Upfront Payment of $350 Million to Accelerate Innovation for Patients in the Growing Alzheimer's Disease Radiodiagnostic Market - GlobeNewsWire
- 4 months ago - Lantheus Holdings: Powerhouse Potential In 2025 - Seeking Alpha